Search

Search Constraints

You searched for: Author/Creator Sweeney, Christopher J.

Search Results

1. A phase 2 trial of abiraterone acetate without glucocorticoids for men with metastatic castration‐resistant prostate cancer. Issue 4 (14th November 2018)

2. A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer. Issue 10 (6th May 2021)

3. Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis. (October 2017)

4. An integrated framework of plant form and function: the belowground perspective. Issue 1 (30th July 2021)

5. Arbuscular Mycorrhizal Fungi and the Need for a Meaningful Regulatory Plant Protection Product Testing Strategy. (14th July 2022)

6. Association between baseline body mass index and survival in men with metastatic hormone‐sensitive prostate cancer: ECOG‐ACRIN CHAARTED E3805. Issue 12 (10th May 2022)

8. Association between very small tumour size and increased cancer‐specific mortality after radical prostatectomy in lymph node‐positive prostate cancer. (31st August 2015)

9. Association of androgen‐deprivation therapy with excess cardiac‐specific mortality in men with prostate cancer. (29th October 2014)